14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CXRX
Delisted

Concordia Healthcare Corp. Fund Predictions

$0.190
+0 (+0%)
At Close: Jun 13, 2018
Currently predicting for Mon, 24 Jun 2024

Trading levels for CXRX

Fibonacci Support & Resistance Levels

Level Price
R3 0.190 0.00000000%
R2 0.190 0.00000000%
R1 0.190 0.00000000%
Price 0.190
S1 0.190 0.00000000%
S2 0.190 0.00000000%
S3 0.190 0.00000000%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.231 21.32%
R2 0.205 7.79%
R1 0.193 1.32%
Price 0.190
S1 0.189 -0.526%
S2 0 -
S3 0 -

CXRX Predictions History

6 years ago
JS predicted that CXRX for 2017-07-17 is going $1.75 (10.06%)

6 years ago
bbullish2 predicted that CXRX for 2017-07-17 is going $1.71 (-2.85%)

6 years ago
Rjm predicted that CXRX for 2017-07-17 is going $2.00 (13.63%)

Rank:

7 years ago
JS predicted that CXRX for 2017-02-09 is going $3.00 (5.63%)

7 years ago
James.Milling.2678 predicted that CXRX for 2017-02-09 is going $1.58 (-41.26%)

Rank:

7 years ago
JS predicted that CXRX for 2017-01-05 is going $2.42 (3.86%)

7 years ago
Mohammad.Hamzeh.1653 predicted that CXRX for 2016-12-22 is going $3.35 (50.90%)

Rank:

7 years ago
Xabulon predicted that CXRX for 2016-08-10 is going $18.00 (5.57%)

Rank:
Click to get the best stock tips daily for free!

About Concordia Healthcare Corp.

Concordia International Corp., a specialty pharmaceutical company, owns a portfolio of branded and generic prescription products in the United States and internationally. The company’s Concordia North America segment has product right sales of pharmaceutical products primarily in the United States. This segment offers a portfolio of branded and generic products, including Donnatal for the treatment of irritable bowel syndrome; Zonegran for the t... CXRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT